3 years ago
386
GAITHERSBURG, Md. (AP) — Vaccine shaper Novavax announced Thursday it has asked regulators successful India, Indonesia and the Philippines to let exigency usage of its COVID-19 vaccine — offering its changeable to immoderate low-income countries earlier affluent ones with ample supplies.
U.S.-based Novavax partnered with the Serum Institute of India to use successful the 3 countries, and plans aboriginal this period to besides question the World Health Organization reappraisal needed to beryllium portion of the COVAX planetary vaccine program.
READ MORE: Weather Blog: Hot, But Not Humid
Novavax CEO Stanley Erck called the submissions an “important measurement toward entree to millions of doses of a harmless and effectual vaccine for countries with an urgent request to power the pandemic.”
The institution announced it besides plans to taxable applications successful Britain soon, followed by Europe, Australia, Canada and New Zealand, but not successful the U.S. until aboriginal successful the year.
The Novavax two-dose changeable is made with lab-grown copies of the spike macromolecule that coats the coronavirus. That’s precise antithetic than different wide utilized vaccines that present familial instructions for the assemblage to marque its ain spike protein.
The Novavax shots are easier to store and transport than immoderate different options, and person agelong been expected to play an important relation successful expanding supplies successful mediocre countries hopeless for much vaccine.
In June, Novavax announced the vaccine had proved about 90% effective against symptomatic COVID-19 successful a survey of astir 30,000 radical successful the U.S. and Mexico. It besides worked against variants circulating successful those countries astatine the time. Side effects were mostly mild.
As for the highly contagious delta variant that present is circulating successful overmuch of the world, Novavax besides announced Thursday that giving a booster six months aft a 2nd changeable revved up virus-fighting antibodies that could tackle that mutant.
Additional studies successful Britain and elsewhere are investigating if the Novavax changeable could beryllium utilized arsenic a booster aft different types of COVID-19 vaccines. Erck said that mix-and-match information mightiness pb to its vaccine becoming “the cosmopolitan booster of choice” successful affluent countries.
And the institution said Indonesia already had expressed involvement successful utilizing the Novavax vaccine arsenic a booster pursuing immoderate Chinese-made shots.
The Gaithersburg, Maryland, institution said it was connected way to nutrient up to 100 cardinal doses a period by the extremity of the 3rd 4th and 150 cardinal doses a period by year’s end.
CBS Baltimore Staff
English (US) ·